Cancer immunotherapy: are the results discouraging? Can they be improved?
Kedar
E
E
Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Klein
E
E
D000818:Animals; D016207:Cytokines / Q000627:therapeutic use; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007167:Immunotherapy; D016219:Immunotherapy, Adoptive; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines; D006649:Histocompatibility Antigens